In the present grant period we have made excellent progress in three general areas: understanding the mechanism of inhibition of HIV-induced membrane fusion by class A amphipathic helixes, developing a theory to explain the mechanism of action of the HIV fusion peptide, and understanding the properties of the amphipathic helixes in gp41. Specifically, we have made the following findings: (a) Class A amphipathic helixes are powerful inhibitors of membrane fusion induced by HIV and other enveloped viruses. (b) Class A amphipathic helixes stabilize bilayers, inhibit fusion of model membranes and inhibit membrane lysis by class L (lytic) amphipathic helixes; the latter appear to destabilize the bilayer lipid phase by stabilizing inverted lipid phases. (c) A molecular model (the reciprocal wedge hypothesis) that effectively explains the reciprocal effects of class A and class L amphipathic helixes on membranes was developed and tested. (d) A novel molecular model for the mechanism of action of HIV fusion peptides, called the beta-wedge, has been proposed that is inspired by the reciprocal wedge hypothesis; preliminary CD studies indicate that peptide analogs of viral fusion peptides have beta structure in solution. (e) Peptide analogs of the two C-terminal amphipathic helixes of gp41 were found to inhibit HIV-induced membrane fusion and were cytotoxic to cells. (f) Peptide analogs of the two gp41 amphipathic helixes (and gp160 but not gp120) were shown to bind to calmodulin and to inhibit its activity in vitro. (g) HDL was found to be significantly lower in asymptomatic HIV positive patients than in controls but the clinical significance of this observation has not been established. We propose the following specific aims: (1) Elucidate the basic molecular mechanism of action of class A and class L amphipathic helixes to produce peptide and nonpeptide analogs with increasing abilities to stabilize or destabilize bilayers. (2) Investigate the molecular mechanism of action of the HIV fusion peptide to develop new anti-fusion peptides and nonpeptide antagonists. (3) Continue our studies of the properties and function of amphipathic helixes in gp4l. New methodological directions include: (a) collaborations with Drs. Bill Gallaher and Eric Hunter to explore molecular mechanisms of fusion and fusion inhibition through the use of site-directed mutagenesis, and (b) Silicon Graphics-based molecular modeling of fusion inducing and inhibiting peptides and non-peptide antagonists.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI028928-04A2
Application #
3143598
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1989-12-01
Project End
1997-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Radding, W; Williams, J P; McKenna, M A et al. (2000) Calmodulin and HIV type 1: interactions with Gag and Gag products. AIDS Res Hum Retroviruses 16:1519-25
Tytler, E M; Anantharamaiah, G M; Walker, D E et al. (1995) Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry 34:4393-401
Segrest, J P; Jones, M K; Mishra, V K et al. (1994) apoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains. Detection by the computer program LOCATE. Arterioscler Thromb 14:1674-85
Srinivas, S K; Srinivas, R V; Anantharamaiah, G M et al. (1993) Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem 268:22895-9
Hazelrig, J B; Jones, M K; Segrest, J P (1993) A mathematically defined motif for the radial distribution of charged residues on apolipoprotein amphipathic alpha helixes. Biophys J 64:1827-32
Tytler, E M; Segrest, J P; Epand, R M et al. (1993) Reciprocal effects of apolipoprotein and lytic peptide analogs on membranes. Cross-sectional molecular shapes of amphipathic alpha helixes control membrane stability. J Biol Chem 268:22112-8
Jones, M K; Anantharamaiah, G M; Segrest, J P (1992) Computer programs to identify and classify amphipathic alpha helical domains. J Lipid Res 33:287-96
Segrest, J P; Jones, M K; De Loof, H et al. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 33:141-66
Srinivas, S K; Srinivas, R V; Anantharamaiah, G M et al. (1992) Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem 267:7121-7